These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 13750156)

  • 1. [Therapeutic trials with galantamine in Duchenne-Griesinger-type progressive muscular dystrophy].
    SERAFINI L; BONVINI E
    Rass Clin Sci; 1961 Jan; 37():20-4. PubMed ID: 13750156
    [No Abstract]   [Full Text] [Related]  

  • 2. [The use of galantamine bromhydrate (nivaline) in the paralytic sequelae of poliomyelitis, neuraxitis and in muscular dystrophy].
    LOMBARDO G; ARENA G
    Minerva Pediatr; 1962 Jun; 14():724-8. PubMed ID: 14466410
    [No Abstract]   [Full Text] [Related]  

  • 3. [Electroencephalographic observations in children with progressive muscular dystrophy treated with galantamine].
    DI GRUTTOLA G; FANUELE G; BERNI CANANIM
    Boll Soc Ital Biol Sper; 1961 Oct; 37():1018-21. PubMed ID: 13886007
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pseudohypertrophy of the diaphram in a case of protopathic progressive muscular dystrophy (Duchenne-Griesinger type)].
    GALLORO V; LAVITOLA G
    Riv Anat Patol Oncol; 1960 Jun; 17():831-42. PubMed ID: 13703192
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular approaches to therapy for Duchenne and limb-girdle muscular dystrophy.
    Stedman HH
    Curr Opin Mol Ther; 2001 Aug; 3(4):350-6. PubMed ID: 11525558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Observations on the use of Galanthamine in 4 cases of progressive muscular dystrophy].
    SANTOLINI BM; DE CARLO M; MENNELLA G
    Minerva Ortop; 1961 Aug; 12():583-7. PubMed ID: 14497060
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic strategy for muscular dystrophies].
    Shin JH; Takeda S
    Brain Nerve; 2007 Apr; 59(4):415-24. PubMed ID: 17447528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of exercise in Duchenne muscular dystrophy.
    Scott OM; Hyde SA; Goddard C; Jones R; Dubowitz V
    Physiotherapy; 1981 Jun; 67(6):174-6. PubMed ID: 7029578
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Change of serum creatine phosphokinase activity after exercise in Duchenne type of progressive muscular dystrophy.
    Nakane K
    Nagoya Med J; 1972 Feb; 17(3):203-16. PubMed ID: 5050757
    [No Abstract]   [Full Text] [Related]  

  • 11. The muscular dystrophies.
    Seiler J; Bope ET
    Am Fam Physician; 1986 Jul; 34(1):123-8. PubMed ID: 3728255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The principles of gene therapy in Duchenne muscular dystrophy.
    Karpati G; Acsadi G
    Clin Invest Med; 1994 Oct; 17(5):499-509. PubMed ID: 7867254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Updates in muscular dystrophies].
    Erazo-Torricelli R
    Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatments for muscular dystrophy: increased treatment options for Duchenne and related muscular dystropies.
    Wells DJ
    Gene Ther; 2008 Aug; 15(15):1077-8. PubMed ID: 18528429
    [No Abstract]   [Full Text] [Related]  

  • 15. Outlook for therapy in the muscular dystrophies.
    Tawil R
    Semin Neurol; 1999; 19(1):81-6. PubMed ID: 10711991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical medicine and rehabilitation: its value and limitations in progressive muscular dystrophy.
    HOBERMAN M
    Am J Phys Med; 1955 Feb; 34(1):109-15. PubMed ID: 14361678
    [No Abstract]   [Full Text] [Related]  

  • 17. [Duchenne muscular dystrophy: clinical analysis and prospects of genetic therapy].
    Mateos F
    Rev Neurol; 1995; 23 Suppl 3():S404-7. PubMed ID: 7497322
    [No Abstract]   [Full Text] [Related]  

  • 18. Muscular dystrophies: influence of physical conditioning on the disease evolution.
    Ansved T
    Curr Opin Clin Nutr Metab Care; 2003 Jul; 6(4):435-9. PubMed ID: 12806218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duchenne muscular dystrophy.
    Gorospe JR; Hoffman EP
    Curr Opin Rheumatol; 1992 Dec; 4(6):794-800. PubMed ID: 1457273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pulmonary monitoring and treatment plan for children with Duchenne-type muscular dystrophies.
    Warren RH; Alderson SH
    J Ark Med Soc; 1996 Dec; 93(7):333-7. PubMed ID: 8990764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.